133 related articles for article (PubMed ID: 25301995)
1. Biodistribution of antibody-targeted and non-targeted iron oxide nanoparticles in a breast cancer mouse model.
Tate JA; Kett W; NDong C; Griswold KE; Hoopes PJ
Proc SPIE Int Soc Opt Eng; 2013 Feb; 8584():85840G. PubMed ID: 25301995
[TBL] [Abstract][Full Text] [Related]
2. Iron oxide nanoparticle hyperthermia and chemotherapy cancer treatment.
Petryk A; Giustini A; Ryan P; Strawbridge R; Hoopes P
Proc SPIE Int Soc Opt Eng; 2009 Feb; 7181():71810N. PubMed ID: 25346581
[TBL] [Abstract][Full Text] [Related]
3. Assessment of intratumor non-antibody directed iron oxide nanoparticle hyperthermia cancer therapy and antibody directed IONP uptake in murine and human cells.
Hoopes P; Tate J; Ogden J; Strawbridge R; Fiering S; Petryk A; Cassim S; Giustini A; Demidenko E; Ivkov R; Barry S; Chinn P; Foreman A
Proc SPIE Int Soc Opt Eng; 2009 Feb; 7181():71810P. PubMed ID: 25346583
[TBL] [Abstract][Full Text] [Related]
4. Biodistribution and targeting properties of iron oxide nanoparticles for treatments of cancer and iron anemia disease.
Alphandéry E
Nanotoxicology; 2019 Jun; 13(5):573-596. PubMed ID: 30938215
[TBL] [Abstract][Full Text] [Related]
5. Targeting of systemically-delivered magnetic nanoparticle hyperthermia using a noninvasive, static, external magnetic field.
Zulauf GD; Trembly BS; Giustini AJ; Flint BR; Strawbridge RR; Hoopes PJ
Proc SPIE Int Soc Opt Eng; 2013 Feb; 8584():85840C. PubMed ID: 24073325
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution and imaging of fluorescently-tagged iron oxide nanoparticles in a breast cancer mouse model.
Tate JA; Savellano MD; Hoopes PJ
Proc SPIE Int Soc Opt Eng; 2013 Feb; 8584():85840I. PubMed ID: 25301997
[TBL] [Abstract][Full Text] [Related]
7. Alternating magnetic field-induced hyperthermia increases iron oxide nanoparticle cell association/uptake and flux in blood-brain barrier models.
Dan M; Bae Y; Pittman TA; Yokel RA
Pharm Res; 2015 May; 32(5):1615-25. PubMed ID: 25377069
[TBL] [Abstract][Full Text] [Related]
8. Toxicity and Biodistribution of Activated and Non-activated Intravenous Iron Oxide Nanoparticles.
Tate J; Ogden J; Strawbridge R; Pierce Z; Hoopes P
Proc SPIE Int Soc Opt Eng; 2009 Feb; 7181():71810L. PubMed ID: 25300674
[TBL] [Abstract][Full Text] [Related]
9. Targeting tumor cells using magnetic nanoparticles - a feasibility study in animal models.
Goren K; Neelam N; Yuval JB; Weiss DJ; Kunicher N; Margel S; Mintz Y
Minim Invasive Ther Allied Technol; 2022 Oct; 31(7):1086-1095. PubMed ID: 36148547
[TBL] [Abstract][Full Text] [Related]
10. Development of a biodegradable iron oxide nanoparticle gel for tumor bed therapy.
Cunkelman B; Chen E; Petryk A; Tate J; Thappa S; Collier R; Hoopes P
Proc SPIE Int Soc Opt Eng; 2013 Feb; 8584():858411. PubMed ID: 25346584
[TBL] [Abstract][Full Text] [Related]
11. In Vivo Imaging and Quantification of Iron Oxide Nanoparticle Uptake and Biodistribution.
Hoopes PJ; Petryk AA; Gimi B; Giustini AJ; Weaver JB; Bischof J; Chamberlain R; Garwood M
Proc SPIE Int Soc Opt Eng; 2012 Mar; 8317():. PubMed ID: 25285189
[TBL] [Abstract][Full Text] [Related]
12. An
Giustini AJ; Ivkov R; Hoopes PJ
Proc SPIE Int Soc Opt Eng; 2009 Feb; 7181():71810M. PubMed ID: 25301988
[TBL] [Abstract][Full Text] [Related]
13. Magnetic nanoparticle biodistribution following intratumoral administration.
Giustini AJ; Ivkov R; Hoopes PJ
Nanotechnology; 2011 Aug; 22(34):345101. PubMed ID: 21795772
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral Iron Oxide Nanoparticle Hyperthermia and Radiation Cancer Treatment.
Hoopes P; Strawbridge R; Gibson U; Zeng Q; Pierce Z; Savellano M; Tate J; Ogden J; Baker I; Ivkov R; Foreman A
Proc SPIE Int Soc Opt Eng; 2007 Feb; 6440():64400K. PubMed ID: 25301985
[TBL] [Abstract][Full Text] [Related]
15. Bio-synthesized iron oxide nanoparticles for cancer treatment.
Alphandéry E
Int J Pharm; 2020 Aug; 586():119472. PubMed ID: 32590095
[TBL] [Abstract][Full Text] [Related]
16. Iron Oxide Hyperthermia And Radiation Cancer Treatment.
Cassim S; Giustini A; Petryk A; Strawbridge R; Hoopes P
Proc SPIE Int Soc Opt Eng; 2009 Feb; 7181():71810O. PubMed ID: 25346582
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution and histological analysis of iron oxide-dextran nanoparticles in wistar rats.
Hannon G; Bogdanska A; Keogh A; Finn SP; Gobbo OL; Prina-Mello A
Nanotoxicology; 2023 Dec; 17(8-9):562-580. PubMed ID: 37982374
[TBL] [Abstract][Full Text] [Related]
18. Stimuli-controllable iron oxide nanoparticle assemblies: Design, manipulation and bio-applications.
Low LE; Lim HP; Ong YS; Siva SP; Sia CS; Goh BH; Chan ES; Tey BT
J Control Release; 2022 May; 345():231-274. PubMed ID: 35306119
[TBL] [Abstract][Full Text] [Related]
19. Functionalized graphene oxide-based thermosensitive hydrogel for magnetic hyperthermia therapy on tumors.
Zhu X; Zhang H; Huang H; Zhang Y; Hou L; Zhang Z
Nanotechnology; 2015 Sep; 26(36):365103. PubMed ID: 26291977
[TBL] [Abstract][Full Text] [Related]
20. The effect of mechanical properties of iron oxide nanoparticle-loaded functional nano-carrier on tumor targeting and imaging.
Choi WI; Kim JY; Heo SU; Jeong YY; Kim YH; Tae G
J Control Release; 2012 Sep; 162(2):267-75. PubMed ID: 22824783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
